文献速递肝胆胰外科围术期管理与 ERAS

右肝切除术中逆行流出道低温灌注安全可行

Hypothermic perfusion with retrograde outflow during right hepatectomy is safe and feasible.
PubMed 文献 · Surgery · 2017-03-24

这项随机预试验在择期右(扩大)肝切除患者中比较逆行流出道原位低温灌注与间歇性肝血流阻断,每组9例。结果显示两组转氨酶峰值、总胆红素和国际标准化比值相似,低温灌注组术后第3天功能性肝再生改善,临床结局相当,提示该技术在健康肝实质患者中安全可行。

要点

  • 逆行流出道低温灌注目标肝核心温度为28°C
  • 两组转氨酶峰值、总胆红素和INR相似
  • 低温灌注组术后第3天功能性肝再生改善

核心结论

  • 在健康肝实质的择期右(扩大)肝切除患者中,逆行流出道原位低温灌注安全可行,并可能促进早期功能性肝再生。

研究设计与样本

  • 随机预试验,先筛查肝实质疾病并排除脂肪变≥30%、肝硬化或胆汁淤积患者,术中随机分为逆行流出道原位低温灌注组(n=9)和间歇性肝血流阻断组(n=9)。

主要发现

  • 两组转氨酶峰值、总胆红素和国际标准化比值相似,低温灌注组总胆红素正常化有更快趋势。
  • 肝胆闪烁显像评估的功能性肝再生在低温灌注组术后第3天改善,而间歇性肝血流阻断组未改善。
  • 低温灌注需持续缺血,但其术后并发症和住院时间等所有临床结局与间歇性肝血流阻断相当。

关键数值与推荐

  • 逆行流出道原位低温灌注的目标肝核心温度为28°C。
  • 排除标准包括脂肪变≥30%、肝硬化或胆汁淤积。
  • 主要终点为缺血再灌注损伤,以术后转氨酶峰值表示。

临床怎么用

  • 对健康肝实质需行右(扩大)肝切除的患者,可考虑采用逆行流出道原位低温灌注以减轻缺血再灌注损伤并促进早期肝功能恢复。
  • 该技术需持续血管流入阻断,适用于预计需长时间阻断的复杂肝切除。

局限性

  • 本研究为随机预试验,样本量小(每组9例),结论需更大规模研究验证。
  • 研究仅纳入健康肝实质患者,对损伤肝实质患者的适用性尚未确定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In situ hypothermic perfusion during liver resection performed under vascular inflow occlusion decreases hepatic ischemia-reperfusion injury, but technical limitations have restricted its widespread use. In situ hypothermic perfusion with retrograde outflow circumvents these impediments and thus could extend the applicability of in situ hypothermic perfusion. The safety and feasibility of in situ hypothermic perfusion with retrograde outflow were analyzed in selected patients undergoing right (extended) hepatectomy and compared to intermittent vascular inflow occlusion, the gold standard method, in this randomized pilot study. METHODS: Patients were first screened for parenchymal liver disease (exclusion criteria: steatosis ≥30%, cirrhosis, or cholestasis). Study participants were randomized intraoperatively to undergo in situ hypothermic perfusion with retrograde outflow (n = 9) or intermittent vascular inflow occlusion (n = 9). The target liver core temperature during in situ hypothermic perfusion with retrograde outflow was 28°C. The primary end point was ischemia-reperfusion injury (expressed by peak postoperative transaminase levels). Secondary outcomes included functional liver regeneration (assessed by hepatobiliary scintigraphy) and clinical outcomes. RESULTS: Peak transaminase levels, total bilirubin, and the international normalized ratio were similar between both groups, although a trend toward more rapid normalization of bilirubin levels was noted for the in situ hypothermic perfusion with retrograde outflow group. Functional liver regeneration as evaluated by hepatobiliary scintigraphy was improved on postoperative day 3 fafter in situ hypothermic perfusion with retrograde outflow but not after intermittent vascular inflow occlusion. Furthermore, in situ hypothermic perfusion with retrograde outflow (requiring continuous ischemia) was comparable to intermittent vascular inflow occlusion for all clinical outcomes, including postoperative complications and hospital stay. CONCLUSION: The use of in situ hypothermic perfusion with retrograde outflow appears to be safe and feasible in selected patients with healthy liver parenchyma and may benefit early functional liver regeneration. Future applications of in situ hypothermic perfusion with retrograde outflow include patients with damaged liver parenchyma who would require major hepatic resection with a prolonged vascular inflow occlusion duration.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Reiniers MJ, Olthof PB, van Golen RF, et al. Hypothermic perfusion with retrograde outflow during right hepatectomy is safe and feasible. Surgery. 2017. PMID: 28343696. doi:10.1016/j.surg.2017.01.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。